全文获取类型
收费全文 | 9333篇 |
免费 | 635篇 |
国内免费 | 57篇 |
专业分类
耳鼻咽喉 | 105篇 |
儿科学 | 237篇 |
妇产科学 | 244篇 |
基础医学 | 1278篇 |
口腔科学 | 738篇 |
临床医学 | 795篇 |
内科学 | 2279篇 |
皮肤病学 | 256篇 |
神经病学 | 909篇 |
特种医学 | 133篇 |
外科学 | 938篇 |
综合类 | 54篇 |
一般理论 | 2篇 |
预防医学 | 799篇 |
眼科学 | 179篇 |
药学 | 505篇 |
中国医学 | 47篇 |
肿瘤学 | 527篇 |
出版年
2024年 | 16篇 |
2023年 | 145篇 |
2022年 | 275篇 |
2021年 | 482篇 |
2020年 | 283篇 |
2019年 | 400篇 |
2018年 | 433篇 |
2017年 | 302篇 |
2016年 | 351篇 |
2015年 | 405篇 |
2014年 | 506篇 |
2013年 | 595篇 |
2012年 | 823篇 |
2011年 | 829篇 |
2010年 | 431篇 |
2009年 | 328篇 |
2008年 | 606篇 |
2007年 | 518篇 |
2006年 | 392篇 |
2005年 | 392篇 |
2004年 | 336篇 |
2003年 | 283篇 |
2002年 | 215篇 |
2001年 | 82篇 |
2000年 | 58篇 |
1999年 | 65篇 |
1998年 | 43篇 |
1997年 | 25篇 |
1996年 | 25篇 |
1995年 | 16篇 |
1994年 | 14篇 |
1993年 | 19篇 |
1992年 | 42篇 |
1991年 | 53篇 |
1990年 | 31篇 |
1989年 | 22篇 |
1988年 | 23篇 |
1987年 | 22篇 |
1986年 | 15篇 |
1985年 | 17篇 |
1984年 | 10篇 |
1983年 | 12篇 |
1980年 | 5篇 |
1979年 | 8篇 |
1978年 | 8篇 |
1977年 | 10篇 |
1976年 | 10篇 |
1974年 | 5篇 |
1973年 | 7篇 |
1966年 | 5篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
Dayane Raquel de Paula Fabiane Barbero Klem Pedro Gabriel Lorencetti Carolina Muller Valderilio Feijó Azevedo 《Clinical rheumatology》2013,32(2):281-283
About a quarter of sclerodermic patients present calcinosis. However, patients with limited form of the disease are more likely to have calcinosis than patients with diffuse form. We report a case of a 54-year-old female patient with limited cutaneous scleroderma using rituximab (RTX) to treat lung fibrosis and arthritis. Into RTX treatment, she also had a complete resolution of calcinosis in her hands. The patient reported improvement in dyspnea and synovitis after two courses of RTX (four weekly infusions 375 mg/m2 each). After 7 months of the first infusion, the calcinosis in her fingers had a complete remission, especially the right thumb. Based on current evidences, we discuss the use of rituximab as a promising therapy to treat not only lung disease but also calcinosis in patients with scleroderma. 相似文献
82.
83.
84.
Development of DNA vaccines against hemolytic-uremic syndrome in a murine model 总被引:2,自引:0,他引:2 下载免费PDF全文
Capozzo AV Pistone Creydt V Dran G Fernández G Gómez S Bentancor LV Rubel C Ibarra C Isturiz M Palermo MS 《Infection and immunity》2003,71(7):3971-3978
Shiga toxin type 2 (Stx2) produced by Escherichia coli O:157H7 can cause hemolytic-uremic syndrome in children, a disease for which there is neither a vaccine nor an effective treatment. This toxin consists of an enzymatically active A subunit and a pentameric B subunit responsible for the toxin binding to host cells, and also found to be immunogenic in rabbits. In this study we developed eukaryotic plasmids expressing the B subunit gene of Stx2 (pStx2B) and the B subunit plus the gene coding for the A subunit with an active-site deletion (pStx2 Delta A). Transfection of eukaryotic cells with these plasmids produced proteins of the expected molecular weight which reacted with specific monoclonal antibodies. Newborn and adult BALB/c mice immunized with two intramuscular injections of each plasmid, either alone or together with the same vector expressing the granulocyte and monocyte colony-stimulating factor (pGM-CSF), elicited a specific Th1-biased humoral response. The effect of pGM-CSF as an adjuvant plasmid was particularly notable in newborn mice and in pStx2B-vaccinated adult mice. Stx2-neutralizing activity, evaluated in vitro on VERO cell monolayers, correlated with in vivo protection. This is the first report using plasmids to induce a neutralizing humoral immune response against the Stx2. 相似文献
85.
86.
Same molecule but different expression: aging and sepsis trigger NLRP3 inflammasome activation,a target of melatonin 下载免费PDF全文
Huayqui Volt José A. García Carolina Doerrier María E. Díaz‐Casado Ana Guerra‐Librero Luis C. López Germaine Escames Jesús A. Tresguerres Darío Acuña‐Castroviejo 《Journal of pineal research》2016,60(2):193-205
The connection between the innate immune system, clock genes, and mitochondrial bioenergetics was analyzed during aging and sepsis in mouse heart. Our results suggest that the sole NF‐κB activation does not explain the inflammatory process underlying aging; the former also triggers the NLRP3 inflammasome that enhances caspase‐1‐dependent maturation of IL‐1β. In this way, aged mice enter into a vicious cycle as IL‐1β further activates the NF‐κB/NLRP3 inflammasome link. The origin of NF‐κB activation was related to the age‐dependent Bmal1/Clock/RORα/Rev‐Erbα loop disruption, which lowers NAD+ levels, reducing the SIRT1 deacetylase ability to inactivate NF‐κB. Consequently, NF‐κB binding to DNA increases, raising the formation of proinflammatory mediators and inducing mitochondrial impairment. The cycle is then closed with the subsequent NLRP3 inflammasome activation. This paired contribution of the innate immune pathways serves as a catalyst to magnify the response to sepsis in aged compared with young mice. Melatonin administration blunted the septic response, reducing inflammation and oxidative stress, and enhancing mitochondrial function at the levels of nonseptic aged mice, but it did not counteract the age‐related inflammation. Together, our results suggest that, although with different strengths, chronoinflammaging constitutes the biochemical substrate of aging and sepsis, and identifies the NLRP3 inflammasome as a new molecular target for melatonin, providing a rationale for its use in NLRP3‐dependent diseases. 相似文献
87.
88.
Sabrina da Silva Saraiva Fernanda Andrade Orsi Marcos Pereira Santos Tania Machado Silmara Montalvão Carolina Costa-Lima Erich Vinícius de Paula Marina Pereira Colella Joyce Annichino-Bizzacchi 《Journal of thrombosis and thrombolysis》2016,42(1):146-153
The home prothrombin time/international normalized ratio (PT/INR) self-management could be convenient for patients, enhancing treatment compliance and improving the quality of the oral anticoagulation. However, patient self-management (PSM) of oral anticoagulation may not be feasible for up to half of the patients due to cognitive or educational issues. In the present study, we aimed to evaluate the feasibility of a PSM program in a public health medical center that provides care for low-income patients. We also aimed to determine the accuracy of individual point-of-care devices (CoaguChek XS®) during long-term of home manipulation. Patients’ time-in-therapeutic range (TTR) and perception of quality of life, were evaluated at scheduled study-visits to the center. Additionally, the accuracy of individual CoaguChek XS® was evaluated in comparison to the standard automated coagulometer at scheduled study-visits to the center. Twenty-five patients were included in the PSM program. The median TTR of patients was 75 % before inclusion, 72 % at 3 months, 75 % at 6 months and 100 % at 12 months after the beginning of self-management (P = 0.14).The median DASS scores were 64, 63, 61.5 and 71.5 before inclusion and at 3, 6 and 12 months, respectively (P = 0.09). One hundred paired INR values were obtained. Correlation between INR values delivered by individual CoaguChek XS® and the automated coagulometer was 94 % and the mean result bias was 0.07 INR units. The coefficient of correlation and the mean bias between methods was stable during 24 months of follow-up. The present study suggests that PSM is feasible for patients treated in the public health system and that the results delivered by CoaguChek XS® have long-term reliability. 相似文献
89.
90.
Azpiri-Lopez Jose R. Galarza-Delgado Dionicio A. Colunga-Pedraza Iris J. Arvizu-Rivera Rosa I. Cardenas-de la Garza Jesus A. Vera-Pineda Raymundo Davila-Jimenez Jose A. Martinez-Flores Carolina M. Rodriguez-Romero Alejandra B. Guajardo-Jauregui Natalia 《Clinical rheumatology》2021,40(7):2651-2656
Clinical Rheumatology - Rheumatoid arthritis (RA) patients are at increased risk for developing cardiovascular disease, including right heart failure. The evaluation of right ventricle (RV) using... 相似文献